CeMMinars
17.11.2014
Raphael Scharfmann
U1016 INSERM-Institut, Cochin Groupe Hospitalier Cochin-Port-Royal, Paris, France
“Beta Cell Development: From Rodent to Human”
03.11.2014
Óscar Fernández-Capetillo
Spanish National Cancer Research Center, Madrid, Spain
“Targeting oncogene-induced DNA damage for cancer therapy”
06.10.2014
Lucas Pelkmans
Institute of Molecular Life Sciences, University of Zurich, Switzerland
“Cell-intrinsic adaptation of lipid composition to local crowding drives social behavior”
14.07.2014
Kathryn Moore
Departments of Medicine and Cell Biology, NYU Langone Medical Center and School of Medicine, New York, United States
“Mechanisms of chronic inflammation in metabolic diseases”
23.06.2014
Benjamin Cravatt
Department of Chemical Physiology, The Skaggs Institute for Chemical Biology
The Scripps Research Institute, La Jolla, CA, United States
“Activity-based proteomics – applications for enzyme and inhibitor discovery”
31.03.2014
Christopher Glass
Cellular & Molecular Medicine, University of California San Diego, La Jolla, CA, United States
“A genome wide view of macrophage activation”
24.03.2014
Holger Sondermann
Department of Molecular Medicine, Cornell University, Ithaca, NY, United States
“The Ins and Outs of c-di-GMP Signaling in Bacterial Biofilm Formation”
17.02.2014
Thomas Helleday
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
“Targeting MTH1 for de-personlised anti-cancer treatment”
10.02.2014
Janet Kelso
The Minerva Research Group for Bioinformatics, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany
“What we have learned from sequencing ancient genomes”
20.01.2014
Thirumala-Devi Kanneganti
Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, United States
“Regulators of Inflammatory Responses”
13.01.2014
Olli Kallioniemi
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
“Individually optimized cancer therapies for Acute Myeloid Leukemia and beyond”